Martin C Tom1, Nikhil Joshi1, Frank Vicini2, Albert J Chang3, Theodore S Hong4, Timothy N Showalter5, Samuel T Chao1, Suzanne Wolden6, Abraham J Wu6, Douglas Martin7, Zain Husain8, Shahed N Badiyan9, Matthew Kolar1, Tracy Sherertz10, Firas Mourtada11, Gilad N Cohen12, Chirag Shah13. 1. Department of Radiation Oncology, Taussig Cancer Institute, Cleveland, OH. 2. 21st Century Oncology, Michigan Healthcare Professionals, Farmington Hills, MI. 3. Department of Radiation Oncology, UCLA, Los Angeles, CA. 4. Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA. 5. Department of Radiation Oncology, University of Virginia, Charlottesville, VA. 6. Departments of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. 7. Department of Radiation Oncology, Ohio State University, Columbus, OH. 8. Department of Therapeutic Radiology, Yale University, New Haven, CT. 9. Department of Radiation Oncology, Washington University, St. Louis, MO. 10. Department of Radiation Oncology, Kaiser Capitol Hill, Seattle, WA. 11. Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE. 12. Department Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY. 13. Department of Radiation Oncology, Taussig Cancer Institute, Cleveland, OH. Electronic address: csshah27@hotmail.com.
Abstract
PURPOSE: Although radiation therapy has traditionally been delivered with external beam or brachytherapy, intraoperative radiation therapy (IORT) represents an alternative that may shorten the course of therapy, reduce toxicities, and improve patient satisfaction while potentially lowering the cost of care. At this time, there are limited evidence-based guidelines to assist clinicians with patient selection for IORT. As such, the American Brachytherapy Society presents a consensus statement on the use of IORT. METHODS: Physicians and physicists with expertise in intraoperative radiation created a site-directed guideline for appropriate patient selection and utilization of IORT. RESULTS: Several IORT techniques exist including radionuclide-based high-dose-rate, low-dose-rate, electron, and low-energy electronic. In breast cancer, IORT as monotherapy should only be used on prospective studies. IORT can be considered in the treatment of sarcomas with close/positive margins or recurrent sarcomas. IORT can be considered in conjunction with external beam radiotherapy for retroperitoneal sarcomas. IORT can be considered for colorectal malignancies with concern for positive margins and in the setting of recurrent gynecologic cancers. For thoracic, head and neck, and central nervous system malignancies, utilization of IORT should be evaluated on a case-by-case basis. CONCLUSIONS: The present guidelines provide clinicians with a summary of current data regarding IORT by treatment site and guidelines for the appropriate patient selection and safe utilization of the technique. High-dose-rate, low-dose-rate brachytherapy methods are appropriate when IORT is to be delivered as are electron and low-energy based on the clinical scenario.
PURPOSE: Although radiation therapy has traditionally been delivered with external beam or brachytherapy, intraoperative radiation therapy (IORT) represents an alternative that may shorten the course of therapy, reduce toxicities, and improve patient satisfaction while potentially lowering the cost of care. At this time, there are limited evidence-based guidelines to assist clinicians with patient selection for IORT. As such, the American Brachytherapy Society presents a consensus statement on the use of IORT. METHODS: Physicians and physicists with expertise in intraoperative radiation created a site-directed guideline for appropriate patient selection and utilization of IORT. RESULTS: Several IORT techniques exist including radionuclide-based high-dose-rate, low-dose-rate, electron, and low-energy electronic. In breast cancer, IORT as monotherapy should only be used on prospective studies. IORT can be considered in the treatment of sarcomas with close/positive margins or recurrent sarcomas. IORT can be considered in conjunction with external beam radiotherapy for retroperitoneal sarcomas. IORT can be considered for colorectal malignancies with concern for positive margins and in the setting of recurrent gynecologic cancers. For thoracic, head and neck, and central nervous system malignancies, utilization of IORT should be evaluated on a case-by-case basis. CONCLUSIONS: The present guidelines provide clinicians with a summary of current data regarding IORT by treatment site and guidelines for the appropriate patient selection and safe utilization of the technique. High-dose-rate, low-dose-rate brachytherapy methods are appropriate when IORT is to be delivered as are electron and low-energy based on the clinical scenario.
Authors: Li Ma; Junhao Qiang; Heliang Yin; Lin Lin; Yan Jiao; Changying Ma; Xinwei Li; Li Dong; Jinglin Cui; Dongmei Wei; Ankur M Sharma; David L Schwartz; Weikuan Gu; Hong Chen Journal: World J Surg Oncol Date: 2020-06-17 Impact factor: 2.754
Authors: Serguei A Castaneda; Marian Khalili; Jacqueline Emrich; Veronica M Zoghbi; Michael S Weingarten; Mark J Rivard; Wilbur B Bowne; Jaganmohan Poli Journal: Adv Radiat Oncol Date: 2019-07-26
Authors: Rupesh Kotecha; Raees Tonse; Miguel A Ramirez Menendez; Andre Williams; Zuanel Diaz; Martin C Tom; Matthew D Hall; Minesh P Mehta; Reinier Alvarez; Vitaly Siomin; Yazmin Odia; Manmeet S Ahluwalia; Michael W McDermott Journal: Sci Rep Date: 2022-03-16 Impact factor: 4.379
Authors: Gustavo R Sarria; Vera Petrova; Frederik Wenz; Yasser Abo-Madyan; Elena Sperk; Frank A Giordano Journal: Radiat Oncol Date: 2020-05-14 Impact factor: 3.481
Authors: Ana Aurora Díaz Gavela; Blanca Vaquero Barrón; Elia Del Cerro Peñalver; Felipe Couñago Journal: Transl Cancer Res Date: 2020-01 Impact factor: 1.241